| Line Item | 2024-04-27 | Y/Y |
|---|---|---|
| Revenue | $193.0M | +4.8% |
| Cost of Revenue | $73.5M | -5.7% |
| Gross Profit | $119.4M | +12.5% |
| R&D Expense | $95.5M | +24.4% |
| SG&A Expense | $60.2M | +24.8% |
| Operating Income | -$37.1M | -74.5% |
| Pre-tax Income | -$22.7M | -27.0% |
| Income Tax | $5.6M | +511.4% |
| Net Income | -$28.4M |
| Line Item | 2024-04-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.9M | -38.3% |
| Short-term Investments | $343.1M | +214.1% |
| Accounts Receivable | $59.7M | +20.4% |
| Inventory | $25.9M | -43.7% |
| Current Assets | $530.3M | +61.6% |
| Total Assets | $601.9M | +51.5% |
| Current Liabilities | $44.6M | +43.8% |
| Line Item | 2024-04-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.7M | +233.0% |
| Capital Expenditures | $15.7M | -27.9% |
| Investing Cash Flow | -$249.5M | -90.5% |
| Financing Cash Flow | $175.3M | +3488.0% |
| Free Cash Flow | $17.1M | +136.9% |
| -71.4% |
| EPS (Basic) | -$0.18 | -63.6% |
| EPS (Diluted) | -$0.18 | -63.6% |
| Total Liabilities |
| $61.7M |
| +24.3% |
| Stockholders' Equity | $540.2M | +55.4% |